Hartree Partners’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.61M Buy
539,034
+535,034
+13,376% +$10.5M 2.52% 14
2026
Q2
$102K Sell
4,000
-26,000
-87% -$612K 0.02% 105
2026
Q1
$449K Sell
30,000
-20,000
-40% -$341K 0.1% 94
2025
Q4
$728K Buy
+50,000
New +$872K 0.26% 48
2025
Q3
– Sell
-36,000
Closed -$615K – 85
2025
Q2
$615K Buy
+36,000
New +$360K 0.17% 41

Other funds holding CORZ

Hartree Partners's CORZ Position: Q3 2026 in Review

Hartree Partners increased its Core Scientific (CORZ) stake by 13,376% in Q3 2026, buying an estimated $10.5M and bringing the position to 539,034 shares worth $8.61M. The position accounts for 2.52% of the portfolio, ranked #14.

Hartree Partners first reported a position in CORZ in Q2 2025 and has held it in 5 quarters since. 335 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • Hartree Partners held 539,034 shares of Core Scientific worth $8.61M as of Q3 2026.
  • Hartree Partners bought 535,034 Core Scientific shares in Q3 2026, an estimated $10.5M.
  • Core Scientific made up 2.52% of Hartree Partners's portfolio in Q3 2026, its #14 holding.
  • Hartree Partners first reported a position in Core Scientific in Q2 2025 and has held it in 5 quarters since.
  • 335 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on Hartree Partners's 13F filing for Q3 2026, filed 13 Nov 2026.